BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 21707482)

  • 21. Function of ceramide transfer protein for biogenesis and sphingolipid composition of extracellular vesicles.
    Crivelli SM; Giovagnoni C; Zhu Z; Tripathi P; Elsherbini A; Quadri Z; Pu J; Zhang L; Ferko B; Berkes D; Spassieva SD; Martinez-Martinez P; Bieberich E
    J Extracell Vesicles; 2022 Jun; 11(6):e12233. PubMed ID: 35642450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Click reactions with functional sphingolipids.
    Fink J; Seibel J
    Biol Chem; 2018 Sep; 399(10):1157-1168. PubMed ID: 29908120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sphingolipid metabolism: roles in signal transduction and disruption by fumonisins.
    Merrill AH; Sullards MC; Wang E; Voss KA; Riley RT
    Environ Health Perspect; 2001 May; 109 Suppl 2(Suppl 2):283-9. PubMed ID: 11359697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An overview of sphingolipid metabolism: from synthesis to breakdown.
    Gault CR; Obeid LM; Hannun YA
    Adv Exp Med Biol; 2010; 688():1-23. PubMed ID: 20919643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CERT-mediated trafficking of ceramide.
    Hanada K; Kumagai K; Tomishige N; Yamaji T
    Biochim Biophys Acta; 2009 Jul; 1791(7):684-91. PubMed ID: 19416656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Following the flux of long-chain bases through the sphingolipid pathway in vivo using mass spectrometry.
    Martínez-Montañés F; Schneiter R
    J Lipid Res; 2016 May; 57(5):906-15. PubMed ID: 26977056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ceramide Metabolism and Parkinson's Disease-Therapeutic Targets.
    Custodia A; Aramburu-Núñez M; Correa-Paz C; Posado-Fernández A; Gómez-Larrauri A; Castillo J; Gómez-Muñoz A; Sobrino T; Ouro A
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34202192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of bioactive sphingolipids in physiology and pathology.
    Gomez-Larrauri A; Presa N; Dominguez-Herrera A; Ouro A; Trueba M; Gomez-Muñoz A
    Essays Biochem; 2020 Sep; 64(3):579-589. PubMed ID: 32579188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Widespread tissue distribution and synthetic pathway of polyunsaturated C24:2 sphingolipids in mammals.
    Edagawa M; Sawai M; Ohno Y; Kihara A
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Dec; 1863(12):1441-1448. PubMed ID: 30251650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel agents targeting bioactive sphingolipids for the treatment of cancer.
    Adan-Gokbulut A; Kartal-Yandim M; Iskender G; Baran Y
    Curr Med Chem; 2013; 20(1):108-22. PubMed ID: 23244584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction between the PH and START domains of ceramide transfer protein competes with phosphatidylinositol 4-phosphate binding by the PH domain.
    Prashek J; Bouyain S; Fu M; Li Y; Berkes D; Yao X
    J Biol Chem; 2017 Aug; 292(34):14217-14228. PubMed ID: 28652409
    [No Abstract]   [Full Text] [Related]  

  • 32. Ceramide and other sphingolipids in cellular responses.
    Yang J; Yu Y; Sun S; Duerksen-Hughes PJ
    Cell Biochem Biophys; 2004; 40(3):323-50. PubMed ID: 15211031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The sphingolipid salvage pathway in ceramide metabolism and signaling.
    Kitatani K; Idkowiak-Baldys J; Hannun YA
    Cell Signal; 2008 Jun; 20(6):1010-8. PubMed ID: 18191382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53 and regulation of bioactive sphingolipids.
    Heffernan-Stroud LA; Obeid LM
    Adv Enzyme Regul; 2011; 51(1):219-28. PubMed ID: 21035490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural Ligand-Mimetic and Nonmimetic Inhibitors of the Ceramide Transport Protein CERT.
    Hanada K; Sakai S; Kumagai K
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A switchable ceramide transfer protein for dissecting the mechanism of ceramide-induced mitochondrial apoptosis.
    Jain A; Dadsena S; Holthuis JCM
    FEBS Lett; 2020 Nov; 594(22):3739-3750. PubMed ID: 33058150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptomics Reveal Altered Metabolic and Signaling Pathways in Podocytes Exposed to C16 Ceramide-Enriched Lipoproteins.
    Hammad SM; Twal WO; Arif E; Semler AJ; Klein RL; Nihalani D
    Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32045989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology.
    Merrill AH; Schmelz EM; Dillehay DL; Spiegel S; Shayman JA; Schroeder JJ; Riley RT; Voss KA; Wang E
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):208-25. PubMed ID: 9007051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ceramide induced mitophagy and tumor suppression.
    Dany M; Ogretmen B
    Biochim Biophys Acta; 2015 Oct; 1853(10 Pt B):2834-45. PubMed ID: 25634657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CERT and intracellular trafficking of ceramide.
    Hanada K; Kumagai K; Tomishige N; Kawano M
    Biochim Biophys Acta; 2007 Jun; 1771(6):644-53. PubMed ID: 17314061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.